Value
5.3/10data confidence 100%| Component | Sub-score |
|---|---|
| P/E | 4.7 |
| P/S | 9.1 |
| EV/EBITDA | 0.0 |
| Fwd P/E | 6.4 |
| PEG | 5.0 |
| Analyst target | 6.0 |
- ▸Forward P/E: 20.2x
- ▸PEG: 1.50
ENSG · Why this verdict
Why The Ensign Group (ENSG) is rated SELL
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
VerdictSELL
Overall score5.1/10
ConfidenceMEDIUM
MacroNEUTRAL
TrendMatrix Research · core thesis
Engine thesis — one sentence
ENSG has beaten consensus four consecutive quarters and trades roughly 27% below the analyst-derived target of $191.75 with a risk/reward of approximately 3.9-to-1 in your favor, but a severe momentum breakdown — RSI at 25 with falling volume and confirming bearish technicals — and a pending legal news overhang argue for waiting until price stabilizes before establishing a position.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
Thesis pillars
| Pillar | Expectation | Trend |
|---|---|---|
Four straight quarters of beating consensus — most recently $1.85 against a $1.82 estimate — demonstrate consistent operational delivery, with the beat streak intact across varying seasonal conditions. Earnings | The beat streak extends to five consecutive quarters, with EPS surprises remaining positive over the next two reporting periods. | →Stable |
| CounterThe average surprise of 2.4% is narrow, and a business concentrated in skilled nursing facilities at 95.6% of revenue has limited pricing levers; any reimbursement rate pressure or cost inflation could convert these modest beats into misses. | ||
With roughly 27% headroom to the $191.75 analyst-derived target and a risk/reward of approximately 3.9-to-1 in your favor, the current price at $150.71 offers asymmetric upside — a rare setup where the reward materially outpaces the defined risk. Price targets | Stock closes within 5% of the $191.75 target within 12 months as fundamental delivery supports the analyst thesis. | →Stable |
| CounterThe favorable geometry depends on analyst targets holding; if legal headline risk triggers estimate cuts or multiple compression, the take-profit target may be revised down sharply, eliminating the implied upside. | ||
RSI has fallen to 25 — signaling capitulation risk — with falling OBV indicating distribution, and the stock trading below its 200-day moving average; though the moving average slope remains positive at +1.0% over 30 days, suggesting this may be a pullback within an ongoing uptrend rather than a structural break. Momentum breakdown | If momentum recovers, RSI rises above 50 and OBV turns positive over four consecutive weeks, confirming a trend reversal. | ↓Deteriorating |
| CounterA declining RSI approaching 25 with a death cross setup and volume distribution can persist longer than expected — capitulation-level RSI readings in a challenged momentum environment often mark the beginning of extended weakness rather than a buying opportunity. | ||
A legal news gate failure introduces headline risk that may suppress the valuation multiple until the matter resolves, creating a source of volatility independent of fundamental performance. Engine gate (failed) | Legal matter resolves without material adverse finding and fewer than 1 additional legal news gate failure occurs over the next 2 quarters. | →Stable |
| CounterLegal proceedings in the skilled nursing sector are common and do not always carry material financial consequences; if the matter resolves quickly or without penalty, the overhang may lift and accelerate the re-rating toward analyst targets. | ||
Four straight quarters of beating consensus — most recently $1.85 against a $1.82 estimate — demonstrate consistent operational delivery, with the beat streak intact across varying seasonal conditions.
→StableEarnings
- Expectation
- The beat streak extends to five consecutive quarters, with EPS surprises remaining positive over the next two reporting periods.
CounterThe average surprise of 2.4% is narrow, and a business concentrated in skilled nursing facilities at 95.6% of revenue has limited pricing levers; any reimbursement rate pressure or cost inflation could convert these modest beats into misses.
With roughly 27% headroom to the $191.75 analyst-derived target and a risk/reward of approximately 3.9-to-1 in your favor, the current price at $150.71 offers asymmetric upside — a rare setup where the reward materially outpaces the defined risk.
→StablePrice targets
- Expectation
- Stock closes within 5% of the $191.75 target within 12 months as fundamental delivery supports the analyst thesis.
CounterThe favorable geometry depends on analyst targets holding; if legal headline risk triggers estimate cuts or multiple compression, the take-profit target may be revised down sharply, eliminating the implied upside.
RSI has fallen to 25 — signaling capitulation risk — with falling OBV indicating distribution, and the stock trading below its 200-day moving average; though the moving average slope remains positive at +1.0% over 30 days, suggesting this may be a pullback within an ongoing uptrend rather than a structural break.
↓DeterioratingMomentum breakdown
- Expectation
- If momentum recovers, RSI rises above 50 and OBV turns positive over four consecutive weeks, confirming a trend reversal.
CounterA declining RSI approaching 25 with a death cross setup and volume distribution can persist longer than expected — capitulation-level RSI readings in a challenged momentum environment often mark the beginning of extended weakness rather than a buying opportunity.
A legal news gate failure introduces headline risk that may suppress the valuation multiple until the matter resolves, creating a source of volatility independent of fundamental performance.
→StableEngine gate (failed)
- Expectation
- Legal matter resolves without material adverse finding and fewer than 1 additional legal news gate failure occurs over the next 2 quarters.
CounterLegal proceedings in the skilled nursing sector are common and do not always carry material financial consequences; if the matter resolves quickly or without penalty, the overhang may lift and accelerate the re-rating toward analyst targets.
Per-dimension breakdown
Quality
4.3/10data confidence 100%| Component | Sub-score |
|---|---|
| ROE | 5.7 |
| ROA | 3.7 |
| Gross margin | 0.0 |
| Op margin | 3.6 |
| Net margin | 3.5 |
| Current ratio | 4.6 |
| FCF quality | 5.6 |
| Moat | 5.4 |
| Piotroski F | 6.7 |
- ▸Earnings quality warning: 74% FCF/NI
- ▸No competitive moat
Growth
6.0/10data confidence 67%| Component | Sub-score |
|---|---|
| Rev growth | 6.8 |
| EPS growth | 5.3 |
Momentum
2.0/10data confidence 100%| Component | Sub-score |
|---|---|
| RSI | 3.0 |
| MACD | 0.0 |
| OBV | 1.0 |
| MA position | 1.5 |
| Volume | 4.7 |
- ▸Capitulation risk (RSI 26, below 200MA)
- ▸Volume distribution (falling OBV)
- ▸Below 200-MA, MA slope flat
Sentiment
5.5/10data confidence 100%| Component | Sub-score |
|---|---|
| LLM sentiment | 3.5 |
| Analyst rating | 5.0 |
| Price target | 8.4 |
- ▸Analyst upside: 28%
Insider
4.8/10data confidence 75%| Component | Sub-score |
|---|---|
| materiality | 5.0 |
| holder change | 4.4 |
| notable moves | 5.0 |
- ▸Negligible insider selling — $267,693 (0.003% of mkt cap)
Peer rank
5.0/10data confidence 80%| Component | Sub-score |
|---|---|
| value rank | 2.0 |
| quality rank | 5.8 |
| growth rank | 7.9 |
Technical
8.1/10data confidence 100%| Component | Sub-score |
|---|---|
| bollinger | 10.0 |
| support resistance | 8.6 |
| 52w position | 5.8 |
Risk (lower is worse)
6.3/10data confidence 100%| Component | Sub-score |
|---|---|
| short interest | 8.5 |
| days to cover | 7.2 |
| volatility | 6.6 |
| put call | 0.0 |
| implied vol | 6.9 |
| max pain risk | 7.0 |
| beta | 8.8 |
| debt equity | 5.5 |
- ▸Elevated put/call: 14.75
- ▸Concentration risks: 1 HIGH, 1 MED (10-K Item 1A — sized via position_sizing, validated via buy_confidence)
Catalyst
6.0/10data confidence 100%| Component | Sub-score |
|---|---|
| erm | 5.0 |
| earnings history | 10.0 |
| earnings timing | 5.0 |
| surprise avg | 3.9 |
| dividend safety | 6.8 |
| news activity | 5.0 |
- ▸Perfect beat streak: 4Q
How the verdict was assembled
Engine trigger
Multiple concerning factors. Consider reducing position.
Engine technical detail
verdict_path:
L4:PATH_F_SELLPassed (7)
- ASYMMETRY:2.2>=1.5
- INSIDER:OK
- 8K:CLEAN
- NEWS_EVENTS:NONE_RECENT
- EARNINGS_PROXIMITY:63d clear
- SEMI_CYCLE_PEAK:CLEAR
- MATERIALS_CYCLE_PEAK:CLEAR
Failed (2)
- MOMENTUM:2.0<4.5
- DEATH_CROSS:HARD_BLOCK
Warning (0)
none
Reward-to-Risk
2.22
Upside
+11.1%
Downside
5.0%
Sizing output
AVOID
SetupFalling Knife — Death cross, below all MAs, RSI 26, MACD bearish
EdgeNo clear edge — No clear edge identified
SuitabilityModerate — Balanced profile
Investment implication
The F-path SELL output reflects an overall score of 5.1 below the 5.6 soft trigger — multiple weakening dimensions accumulated rather than a single hard-floor breach. The strongest dimension ( Technical at 8.1) was not enough to lift the adjusted overall above the threshold. Co-occurring failed gates ( MOMENTUM:2.0<4.5, DEATH_CROSS:HARD_BLOCK) reinforce the read. Current asymmetry R:R is 2.22 — supplementary context, not the trigger for this path.
The strongest dimensions are Technical at 8.1, Risk (lower is worse) at 6.3, and Growth at 6.0; the weakest are Momentum at 2.0, Quality at 4.3, and Insider at 4.8. The V9 engine flagged 2 failed gates, producing an asymmetric reward-to-risk of 2.22 and an engine sizing output of AVOID.
What would invalidate the thesis
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1Four Consecutive Earnings Beats
Trip ifEPS surprise falls below 0% for 2 consecutive quarters.
- P2Favorable Risk Reward Geometry
Trip ifAnalyst consensus price target is revised down more than $45 from $191.75 to below $148, placing it at or below current price levels and eliminating the upside thesis.
- P3Momentum Breakdown Blocks Entry
Trip ifRSI rises above 50 and OBV turns upward for 4 consecutive weeks, confirming that the pullback has reversed into a renewed uptrend.
- P4Legal News Overhang Suppresses Multiple
Trip ifLegal matter resolves without adverse finding and fewer than 1 additional legal news gate failure occurs over 2 consecutive quarters.